Skip to content
Clinical Trials – home
Mylan Inc.
Sponsor

Mylan Inc.

United States 1000 Mylan Boulevard, 15317-5853, United States

About the sponsor

Clinical research activity is centered on major depressive disorder, with attention to patients whose symptoms remain insufficiently controlled by existing antidepressant therapy. The sponsor’s studies examine both oral and injectable approaches used alongside ongoing antidepressant treatment.

  • Adjunctive antidepressant treatment
  • Treatment-resistant depression
  • Depressive symptom reduction

Outcomes are focused on changes in established depression rating scales and the broader management of persistent depressive symptoms.

About Specializations

Mylan Inc. runs clinical trials in conditions such as Major depression, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Study on the Effectiveness and Safety of Ademetionine Injections for Patients with Major Depressive Disorder Not Responding to Antidepressants

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Ademetionine
  • Sponsor:Mylan Inc.

Study on the Effectiveness and Safety of Ademetionine with Antidepressants for Patients with Major Depressive Disorder

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Ademetionine
  • Sponsor:Mylan Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.